Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law

Damien Geradin, Michael Clancy, Andrew Lazerow

Research output: Contribution to journal › Article › Scientific › peer-review

Access to Document

@article{db6869306e094d82a72056a071c88e10,

title = "Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law",

author = "Damien Geradin and Michael Clancy and Andrew Lazerow",

year = "2014",

doi = "10.1177/0003603X1405900107",

language = "English",

volume = "59",

pages = "153--172",

journal = "Antitrust Bulletin",

issn = "1930-7969",

publisher = "SAGE Publications Inc.",

number = "1",

}

TY - JOUR

T1 - Reverse-payment patent settlements in the pharmaceutical industry

T2 - An analysis of US antitrust law and EU competition law

AU - Geradin, Damien

AU - Clancy, Michael

AU - Lazerow, Andrew

PY - 2014

Y1 - 2014

U2 - 10.1177/0003603X1405900107

DO - 10.1177/0003603X1405900107

M3 - Article

SN - 1930-7969

VL - 59

SP - 153

EP - 172

JO - Antitrust Bulletin

JF - Antitrust Bulletin

IS - 1

ER -